19. Bleeding Patterns Among Adolescents Using the Levonorgestrel Intrauterine Device: A Single Institution Review
1
Citation
0
Reference
10
Related Paper
Citation Trend
Keywords:
Levonorgestrel
Intrauterine device
Uterine bleeding
Levonorgestrel
Intrauterine device
Cite
Citations (5)
Levonorgestrel
Intrauterine device
Cite
Citations (1)
Finley, Deja PharmD; Kheirkhahan, Nazanin MD; Richards, Andrea MD; Wright, Tyler MD Author Information
Levonorgestrel
Emergency Contraception
Intrauterine device
Copper wire
Cite
Citations (0)
Levonorgestrel
Intrauterine device
Metrorrhagia
Cite
Citations (60)
Levonorgestrel
Intrauterine device
Uterine bleeding
Cite
Citations (1)
The intrauterine device (IUD) is the most popular method of reversible contraception in women of reproductive age nowadays, and its use is being reported by nearly 160 million women. It is considered safe and effective, but intrauterine devices are associated with rare complications such as uterine perforation. We report a case of uterine perforation by a levonorgestrel-releasing intrauterine device (LNG-IUD), Mirena (Bayer, Auckland, New Zealand) levonorgestrel 52 mg, to create awareness of the diagnosis and the laparoscopic management of these rare cases.
Levonorgestrel
Intrauterine device
Uterine perforation
Perforation
Cite
Citations (2)
Objective To evaluate the efficacy and safety of a Levonorgestrel-releasing intrauterine device (LNG-IUD) in treatment of adenomyosis.Methods To observe and compare the symptoms of dysmenorrhea,serum CA 125 ,volume of uterus,patterns of menstruation,and side-effect before and after LNG-IUD was inserted.Results The symptom of dysmenorrhea was relieved significantly one month after insertion,scores of pain decreased from 2.7 to 0.7(P0.01),and disappeared six month after insertion.The volume of uterus reduced six months after insertion and later,but without significant change (P0.05).Serum CA 125 reduced significantly(P0.01),down to the normal range three months after insertion,and remained at low level later.Conclusions Treatment of adenomyosis with a Levonorgestrel-releasing intrauterine device is a safe and effective conservative method.
Levonorgestrel
Adenomyosis
Intrauterine device
Menstruation
Cite
Citations (0)
Pain levels may interfere with a patient`s decision when it comes to choosing an appropriate intrauterine system.To our knowledge, there is no study which compares the pain levels during and in the first weeks after the insertion of the levonorgestrel-releasing intrauterine system (LNG-IUS), opposed to copper T380A intrauterine device (C T380A IUD), considering the structural differences between the two devices.In the Department of Obstetrics and Gynecology of University Emergency Hospital Bucharest we prospectively evaluated 100 women, who expressed interest in an IUD, as a form of longacting reversible method of contraception.The subjects were separated into two groups.In the first group (n=50) LNG-IUS was inserted, while in the second group (n=50), the C T380A IUD was placed.All patients were asked to describe the level of pain using a numeric scale during and in the first four weeks after IUD insertion at a follow-up visit.We than compared the levels of pain stated by the patients in the groups immediately after insertion and at the follow-up visit -four weeks after IUD insertion has been made.Rank test statistics confirmed no difference in the level of pain of the patients in the first group, with a levonorgestrel-releasing intrauterine system inserted, and those in the second group, with a copper T380A intrauterine device inserted.
Levonorgestrel
Intrauterine device
Copper wire
Cite
Citations (1)
Levonorgestrel
Intrauterine device
Discontinuation
Cite
Citations (29)